.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Covington
Fuji
Merck
Teva
US Department of Justice
Accenture
Moodys
Fish and Richardson

Generated: November 20, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,402,949

« Back to Dashboard

Summary for Patent: 4,402,949

Title: Stable solutions of hydrogenated ergotalkaloids
Abstract:Stable solutions of (a) hydrogenated ergot alkaloids and (b) heparin as well as the salts thereof in a carrier medium comprising (c) water, (d) a mono- or poly-alcohol, and (e) urea or a pharmaceutically acceptable calcium or magnesium salt or ethylenediaminetetraacetic acid, and combinations thereof.
Inventor(s): Hartmann; Volker (Nuremberg, DE), Otto; Karl-Heinz (Kastl/Opf., DE), Patt; Ludwig (Nuremberg, DE)
Assignee: Sandoz Ltd. (Basel, CH)
Application Number:06/317,660
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Dosage form; Process;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,402,949

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany2945636Nov 12, 1979

International Patent Family for Patent: 4,402,949

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria371997► Subscribe
AustriaA550480► Subscribe
Australia535357► Subscribe
Australia6426580► Subscribe
Belgium886008► Subscribe
Canada1165692► Subscribe
Switzerland650930► Subscribe
Cyprus1332► Subscribe
Germany2945636► Subscribe
Germany3068719► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Healthtrust
Fish and Richardson
US Army
Federal Trade Commission
Baxter
Harvard Business School
Fuji
Julphar
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot